New Zealand Formulary
Menu Close Menu

Fewer cancers.
Better survival.
Equity for all.

Systemic Anti-Cancer Therapy Regimen Library

Home > Urogenital

Urogenital Regimens



Non-Prostate Regimens



Bladder and Urothelial Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GU BLA - mitomycin and fluorouracil chemoradiation
265051000210101
1.0.0
21/08/2023
GU Bladder Urothelial - cISplatin [Q1W] chemoradiation
265451000210109
1.0.0
24/08/2023
GU Bladder Urothelial - gemcitabine [low dose] chemoradiation
265331000210109
1.0.0
24/08/2023
GU Bladder Urothelial Adjuvant - ddMVAC [metHOTREXATe, DOXOrubicin, vinBLASTine and cISplatin] dose dense
265311000210102
1.0.0
24/08/2023
GU Bladder Urothelial Neoadjuvant - cISplatin and gemcitabine
265061000210103
1.0.0
21/08/2023
GU Bladder Urothelial Neoadjuvant - ddMVAC [metHOTREXATe, DOXOrubicin, vinBLASTine and cISplatin] dose dense
265321000210107
1.0.0
24/08/2023
GU Upper Tract Urothelial Adjuvant - cARBOplatin and gemcitabine
264991000210108
1.0.0
21/08/2023
GU Upper Tract Urothelial Adjuvant - cISplatin [split dose] and gemcitabine
391431000210108
1.0.0
28/04/2024
GU Upper Tract Urothelial Adjuvant - cISplatin and gemcitabine
264981000210106
1.0.0
21/08/2023
GU URO Advanced - avelumab Q2W [flat dosing]
265441000210106
1.0.0
24/08/2023
GU URO Advanced - cARBOplatin and gemcitabine
265001000210102
1.0.0
21/08/2023
GU URO Advanced - cISplatin [split dose] and gemcitabine
391441000210100
1.0.0
28/04/2024
GU URO Advanced - cISplatin and gemcitabine
391451000210102
1.0.0
28/04/2024
GU URO Advanced - cISplatin, gemcitabine and nivolumab
496501000210100
1.0.0
21/01/2025
GU URO Advanced - enfortumab vedotin
496761000210106
1.0.0
29/01/2025
GU URO Advanced - enfortumab vedotin and pembrolizumab
496711000210109
1.0.0
29/01/2025
GU URO Advanced - pembrolizumab Q3W [flat dosing]
265131000210106
1.0.0
21/08/2023
GU URO Advanced - pembrolizumab Q6W [flat dosing]
265121000210109
1.0.0
21/08/2023
GU URO Metastatic - PACLItaxel [Q1W]
265191000210107
1.0.0
21/08/2023
GU URO Metastatic - PACLItaxel Q1W and pembrolizumab Q3W [flat dosing]
265351000210103
1.0.0
24/08/2023
GU URO Neoadjuvant/Adjuvant - cISplatin [split dose], gemcitabine and durvalumab
496991000210103
1.0.0
09/02/2025
GU URO Neoadjuvant/Adjuvant - cISplatin, gemcitabine and durvalumab
496981000210100
1.0.0
09/02/2025

Penile Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GU Penile Advanced - TIP [PACLItaxel, IFOSFamide and cISplatin] [3-day]
265301000210104
1.0.0
24/08/2023
GU Penile Advanced - TIP [PACLItaxel, IFOSFamide and cISplatin] [5-day]
265291000210103
2.0.0
19/02/2025
GU Penile Advanced - TPF [DOCEtaxel, cISplatin, fluorouracil]
265281000210100
1.0.0
24/08/2023

Renal Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GU Renal cell Adjuvant - pembrolizumab Q3W [flat dosing]
496461000210100
1.0.0
10/12/2024
GU Renal cell Advanced - nivolumab and ipilimumab induction followed by nivolumab maintenance Q2W [flat dosing]
components ▾
265391000210105
1.0.0
24/08/2023
Part 1: nivolumab and ipilimumab induction
265371000210106
0.0.8
Part 2: nivolumab maintenance Q2W [flat dosing]
265401000210108
0.0.4
GU Renal cell Advanced - nivolumab and ipilimumab induction followed by nivolumab maintenance Q4W [flat dosing]
components ▾
265361000210100
1.0.0
24/08/2023
Part 1: nivolumab and ipilimumab induction
265371000210106
0.0.8
Part 2: nivolumab maintenance Q4W [flat dosing]
265381000210108
0.0.6
GU Renal cell Advanced - nivolumab Q2W [flat dosing]
265171000210108
1.0.0
21/08/2023
GU Renal cell Advanced - nivolumab Q4W [flat dosing]
265161000210102
1.0.0
21/08/2023
GU Renal cell Metastatic - aXITinib
264961000210103
1.0.0
21/08/2023
GU Renal cell Metastatic - aXITinib and pembrolizumab Q3W [flat dosing]
265111000210104
1.0.0
21/08/2023
GU Renal cell Metastatic - aXITinib and pembrolizumab Q6W [flat dosing]
265101000210101
1.0.0
21/08/2023
GU Renal cell Metastatic - beVACizumab and erlotinib
265481000210104
1.0.0
28/08/2023
GU Renal cell Metastatic - cABOZANtinib
264971000210109
1.0.0
21/08/2023
GU Renal cell Metastatic - cABOZANtinib and nivolumab
265421000210100
1.0.0
24/08/2023
GU Renal cell Metastatic - everolimus
265091000210108
1.0.0
21/08/2023
GU Renal cell Metastatic - leNVAtinib and everolimus
265341000210101
2.0.0
03/04/2025
GU Renal cell Metastatic - leNVAtinib and pembrolizumab Q3W [flat dosing]
265181000210105
1.0.0
21/08/2023
GU Renal cell Metastatic - pAZOPanib
265151000210100
1.0.0
21/08/2023
GU Renal cell Metastatic - pembrolizumab Q3W [flat dosing]
265081000210106
1.0.0
21/08/2023
GU Renal cell Metastatic - pembrolizumab Q3W [flat dosing] and ipilimumab
265431000210103
1.0.0
24/08/2023
GU Renal cell Metastatic - pembrolizumab Q6W [flat dosing]
265071000210109
1.0.0
21/08/2023
GU Renal cell Metastatic - sUNITinib
265141000210103
1.0.0
21/08/2023

Discontinued Regimens

Name
Id
Version
Published date
GU Renal cell Metastatic - aXITinib and avelumab [flat dose]
265411000210105
1.0.2
20/08/2025

Testicular Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GU GCT Advanced - EP [etoposide and cISplatin] [3-day]
265471000210101
1.0.0
27/08/2023
GU GCT Advanced - EP [etoposide and cISplatin] [5-day]
265021000210105
2.0.0
19/02/2025
GU GCT Metastatic - BEP [bleomycin, etoposide and cISplatin] [3-day]
265461000210107
1.0.0
27/08/2023
GU GCT Metastatic - BEP [bleomycin, etoposide and cISplatin] [5-day]
265041000210104
2.0.0
19/02/2025
GU GCT Metastatic - TI [PACLItaxel and IFOSFamide] [Part ONE of TICE]
393721000210104
1.0.0
10/10/2024
GU GCT Metastatic - TIP [PACLItaxel, IFOSFamide and cISplatin]
391421000210106
2.0.0
19/02/2025
GU GCT Metastatic - VIP [etoposide, IFOSFamide and cISplatin]
265011000210100
2.0.0
19/02/2025
GU GCT Non-seminoma Adjuvant - BEP [bleomycin, etoposide and cISplatin]
265031000210107
2.0.0
19/02/2025
GU GCT Seminoma Adjuvant - cARBOplatin [7 AUC]
391461000210104
1.0.0
28/04/2024

Prostate Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GU PROS Castration resistant Metastatic - abiraterone and dexamethasone
52451000210102
1.0.0
19/04/2021
GU PROS Castration resistant Metastatic - abiraterone and prEDNISone
52321000210104
1.0.0
02/03/2021
GU PROS Castration resistant Metastatic - apalutamide
393381000210104
1.0.0
18/08/2024
GU PROS Castration resistant Metastatic - cabazitaxel Q3W and prEDNISone
52511000210102
2.0.0
13/08/2023
GU PROS Castration resistant Metastatic - cARBOplatin and DOCEtaxel
52561000210100
3.0.0
13/08/2023
GU PROS Castration resistant Metastatic - DOCEtaxel Q2W and prEDNISone
52391000210101
1.0.0
03/03/2021
GU PROS Castration resistant Metastatic - DOCEtaxel Q3W and prEDNISone
52381000210103
1.0.0
03/03/2021
GU PROS Castration resistant Metastatic - enzalutamide
52531000210109
1.0.0
29/06/2021
GU PROS Castration resistant NON-Metastatic - apalutamide
52441000210100
1.0.0
19/04/2021
GU PROS Castration resistant NON-Metastatic - darolutamide
393161000210105
1.0.0
01/08/2024
GU PROS Castration sensitive Metastatic - abiraterone and prEDNISone
52371000210100
1.0.0
03/03/2021
GU PROS Castration sensitive Metastatic - abiraterone and prEDNISone [fed state]
393701000210107
1.0.0
18/09/2024
GU PROS Castration sensitive Metastatic - abiraterone micronised [Yonsa] and methylprednisolone
506461000210105
1.0.0
28/05/2025
GU PROS Castration sensitive Metastatic - apalutamide
52431000210108
1.0.0
19/04/2021
GU PROS Castration sensitive Metastatic - darolutamide
506541000210108
1.0.0
05/08/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel Q3W
52361000210106
2.0.0
05/08/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel Q3W and darolutamide
506531000210100
1.0.0
05/08/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel, abiraterone [fed state] and prEDNISone
506401000210106
1.0.0
04/05/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel, abiraterone and prEDNISone
393631000210106
1.0.0
05/09/2024
GU PROS Castration sensitive Metastatic - enzalutamide
393101000210106
1.0.0
01/08/2024
GU PROS Castration sensitive NON-Metastatic - apalutamide
393371000210101
1.0.0
18/08/2024
GU PROS Castration sensitive NON-Metastatic - enzalutamide
506381000210106
1.0.0
01/05/2025
GU PROS Locally advanced/Metastatic - degarelix
393091000210104
1.0.0
01/08/2024
GU PROS Metastatic - bicalutamide
52421000210106
1.0.0
19/04/2021
GU PROS Metastatic - cyproterone
52351000210108
1.0.0
03/03/2021
GU PROS Metastatic - denosumab
393081000210101
1.0.0
01/08/2024
GU PROS Metastatic - flutamide
52411000210101
1.0.0
19/04/2021
GU PROS Metastatic - goserelin
52461000210104
1.0.0
19/04/2021
GU PROS Metastatic - olaparib
393061000210109
1.0.0
01/08/2024
GU PROS Metastatic - pembrolizumab [flat dose]
52341000210105
3.0.0
17/10/2022
GU PROS Metastatic - zoledronic acid Q12W
52541000210101
1.0.0
29/06/2021
GU PROS Metastatic - zoledronic acid Q4W
52521000210107
1.0.0
29/06/2021
GU PROS Metastatic - zoledronic acid Q6W
59261000210106
1.0.0
12/05/2022
GU PROS Small cell prostate cancer - cARBOplatin and etoposide
393071000210103
1.0.0
01/08/2024
GU PROS Small cell prostate cancer - cARBOplatin and oral etoposide
393171000210104
1.0.0
01/08/2024

Discontinued Regimens

Name Sort
Id Sort
Version Sort
Published date Sort
GU PROS Castration resistant Metastatic - abiraterone and prEDNISone [fed state]
52311000210109
1.0.2
20/08/2025
GU PROS Metastatic - peptide receptor radionuclide therapy with lutetium Lu 177 vipivotide tetraxetan
393391000210102
1.0.2
20/08/2025